Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Millennnium Pharmaceuticals, Inc.

Millennnium Pharmaceuticals, Inc. Patent applications
Patent application numberTitlePublished
20100093802CCR9 INHIBITORS AND METHODS OF USE THEREOF - The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.04-15-2010